8-K: Wiley Reports Strong Q3 FY26: AI Momentum, Margin Expansion

John Wiley & Sons, Inc. announced robust third-quarter fiscal year 2026 results, highlighted by AI revenue growth, significant margin expansion, and increased cash flow, reaffirming its full-year outlook.

Summary

• GAAP Revenue for the third quarter was $410 million, up 1% from the prior year.
• GAAP Operating Income reached $63 million, a 21% increase compared to the prior year.
• GAAP Diluted Earnings Per Share (EPS) was $0.56, a significant improvement from a loss of ($0.43) in the prior year period.
• Adjusted Revenue at constant currency was $410 million, flat as expected due to unfavorable comparisons in Research and market-related softness in Learning.
• Adjusted Operating Income increased by 22% at constant currency to $70 million, with a margin of 17%, up 280 basis points.
• Adjusted EBITDA grew 12% at constant currency to $105 million, with a margin of 25.7%, up 250 basis points.
• Adjusted EPS was $0.97, up 19% at constant currency.
• AI revenue for the quarter was $7 million, contributing to approximately $42 million year-to-date.
• Operating Cash Flow increased by $51 million year-to-date to $103 million.
• Free Cash Flow improved to $56 million year-to-date, compared to a use of ($1 million) in the prior year.
• Share repurchases totaled $35 million this quarter, with a full-year target of $100 million; $126 million was allocated to share repurchases and dividends year-to-date.
• The company is guiding to the high end of its range for Adjusted EBITDA margin and Adjusted EPS for Fiscal 2026, while reaffirming its Revenue and Free Cash Flow outlook.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong report, demonstrating effective execution of strategic initiatives, particularly in AI and cost management, leading to significant margin and cash flow improvements and an optimistic outlook.

Positives

• GAAP Operating Income increased by 21% to $63 million.
• GAAP Diluted EPS improved significantly to $0.56 from a ($0.43) loss in the prior year.
• Adjusted Operating Income grew 22% at constant currency, with margin expanding 280 basis points to 17%.
• Adjusted EBITDA increased 12% at constant currency, with margin expanding 250 basis points to 25.7%.
• Adjusted EPS rose 19% at constant currency to $0.97.
• Research Publishing revenue grew 3% as reported (+1% at constant currency), or 4% excluding an unfavorable AI agreement comparison.
• Realized $7 million of AI revenue this quarter and approximately $42 million year-to-date, surpassing $100 million in lifetime AI revenue.
• Launched Clinical Outcomes Assessments partnership with IQVIA and announced a strategic partnership with OpenEvidence for AI clinical decision support.
• Reduced Corporate Expenses (Adjusted EBITDA) by 21% at constant currency as part of multi-year margin expansion initiatives.
• Operating Cash Flow increased by $51 million to $103 million year-to-date.
• Free Cash Flow improved to $56 million year-to-date from a use of ($1 million) in the prior year.
• Increased share repurchases to $35 million this quarter, with a full-year target of $100 million.
• Net Debt-to-EBITDA Ratio improved to 1.7 compared to 2.0 in the year-ago period.
• Guiding to the high end of the range for Adjusted EBITDA margin and Adjusted EPS for Fiscal 2026.
• Research segment Adjusted EBITDA margin improved to 33.1% from 32.7% in the prior year period.
• Learning segment Adjusted EBITDA margin increased by twenty basis points to 35.6%.

Negatives

• Adjusted Revenue at constant currency was flat, as expected, due to unfavorable comparisons in Research and market-related softness in Learning.
• Research Solutions revenue was down 3% at constant currency, largely due to softness in recruiting and databases.
• Learning segment revenue was down 1% as reported or 2% at constant currency.
• Professional Learning revenue was down 5% at constant currency due to soft retail channel and market conditions.
• Year-to-date, Learning revenue was down 7% as reported and at constant currency.
• Adjusted EBITDA for the Learning segment was flat as reported and down 1% at constant currency.

Risks

• The level of investment in new technologies and products.
• Subscriber renewal rates for journals.
• The financial stability and liquidity of journal subscription agents.
• The consolidation of book wholesalers and retail accounts.
• The market position and financial stability of key online retailers.
• The seasonal nature of the educational business and the impact of the used book market.
• Worldwide economic and political conditions.
• The ability to protect copyrights and other intellectual property worldwide.
• The ability to successfully integrate acquired operations and realize expected opportunities.
• The ability to realize operating savings over time and in fiscal year 2026 in connection with the multiyear Global Restructuring Program and completed dispositions.
• Cyber risk and the failure to maintain the integrity of operational or security systems or infrastructure, or those of third parties with which the company does business.
• The risk that the company may never realize the full carrying value of goodwill and other identifiable intangible assets recorded as a result of acquisitions.
• The ability to leverage artificial intelligence technologies in products and services, including generative artificial intelligence, large language models, machine learning, and other artificial intelligence tools.

Future Outlook

Wiley is guiding to the high end of its Fiscal 2026 range for Adjusted EBITDA margin (25.5% to 26.5%) and Adjusted EPS ($3.90 to $4.35), while reaffirming its Adjusted Revenue and Free Cash Flow outlook of approximately $200 million. The company anticipates continued strong momentum in Research and AI, with Fiscal 2027 expected to see further Research growth, accelerating AI momentum, fast-tracking operational excellence initiatives, meaningful margin expansion, and a relentless focus on portfolio optimization and disciplined capital allocation to drive higher ROIC and recurring-revenue growth.

Management Comments

• "We continue to accelerate our progress in major areas of focus, from driving Research and AI growth to delivering materially higher margins and cash flow." Matthew Kissner, President and CEO.
• "In Research Publishing, we're leveraging our scale and competitive moat to grow market share and drive record publishing output, with AI as a further accelerator." Matthew Kissner, President and CEO.
• "In AI and data services, we're leveraging our proprietary content and unparalleled partner ecosystem to execute strategic multi-year agreements with corporations in life sciences and other verticals." Matthew Kissner, President and CEO.
• "We recently surpassed $100 million in lifetime AI revenue and secured our first LLM customer outside the US." Matthew Kissner, President and CEO.
• "Finally, margin expansion remains our company-wide ethos as evidenced by our 280 basis point improvement in our Adjusted Operating Margin." Matthew Kissner, President and CEO.

Industry Context

StockSavvy.ai notes that Wiley's strong focus on AI and data services, particularly in life sciences, aligns with broader industry trends of leveraging proprietary content for advanced analytics and decision support. The partnerships with IQVIA and OpenEvidence demonstrate a strategic shift towards higher-value solutions in the clinical trial and point-of-care markets, positioning Wiley competitively against traditional publishers and emerging tech players in the knowledge economy. The emphasis on open access and digital content also reflects the ongoing transformation in scholarly publishing.

Comparison to Industry Standards

• Wiley's 26% increase in article submissions and 11% increase in output year-to-date in Research Publishing indicates robust demand, outperforming general academic publishing growth rates which typically range from low to mid-single digits.
• The 24% growth in Open Access is strong, reflecting a significant shift in the scholarly publishing model, comparable to or exceeding the growth seen by other major publishers like Springer Nature or Elsevier in their open access portfolios.
• The Net Debt-to-EBITDA ratio of 1.7 is healthy and generally below the industry average for mature content companies, indicating strong financial management and capacity for further investment or shareholder returns.
• The strategic partnership with IQVIA, the world's largest Contract Research Organization ($16B annual revenue), for Clinical Outcomes Assessments, positions Wiley in a high-growth segment, similar to how companies like Clarivate leverage data for pharmaceutical R&D.
• The 5-year agreement with OpenEvidence, a platform used by over 40% of U.S. physicians, demonstrates a successful pivot into clinical AI decision support, a market where companies like Wolters Kluwer also compete with specialized content and tools.

Management Changes

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased share repurchases, improved Free Cash Flow, and optimistic outlook, potentially leading to increased share value and returns.
• Employees: Potential impact from 'restructuring savings and expense management across functional areas, namely Technology' and 'technology managed services partnership' which could imply workforce adjustments, though framed as 'operational efficiencies.'
• Customers (Researchers/Institutions): Positive impact from continued investment in Research Publishing, open access models, and AI-powered research capabilities (e.g., Research Exchange, Gateway), enhancing access to content and tools.
• Customers (Corporations/Life Sciences): Positive impact from new AI and data services partnerships (IQVIA, OpenEvidence) providing advanced clinical decision support and data solutions.
• Suppliers/Partners: Strengthened relationships with AI platform providers and other publishers through content licensing and strategic partnerships.

Next Steps

• Continue accelerating progress in Research and AI growth.
• Deliver materially higher margins and cash flow.
• Execute strategic multi-year agreements with corporations in life sciences and other verticals for AI and data services.
• Continue multi-year margin expansion initiatives, including the technology managed services partnership.
• Realize $200 million of Free Cash Flow in Fiscal 2026.
• Achieve full-year target of $100 million in share repurchases for Fiscal 2026.
• Expand the world-leading Advanced brand with 8 new journals planned by the end of 2026.
• Continue to drive ROIC higher through disciplined portfolio and capital allocation.
• Full launch of the Research Exchange Platform.
• Implement AI Center of Excellence initiatives.
• Monitor expected copyright court decisions related to AI.

Key Dates

Recommendation

Wiley's Q3 FY26 results demonstrate robust execution of its strategic transformation, marked by significant margin expansion, strong cash flow generation, and accelerating AI revenue. The company's guidance to the high end of its Adjusted EBITDA and EPS ranges, coupled with increased shareholder returns through buybacks, signals strong confidence in its future performance. The strategic partnerships in AI and the continued strength in Research Publishing position Wiley favorably in the evolving knowledge economy, making it an attractive investment for long-term growth.

Keywords

John Wiley & Sons, Wiley, WLY, WLYB, SEC Filing, 8-K, Earnings Report, Q3 2026, Financial Results, AI Revenue, Artificial Intelligence, Research Publishing, Learning Solutions, Adjusted EBITDA, Adjusted EPS, Free Cash Flow, Margin Expansion, Share Repurchases, Digital Content, Open Access, Clinical Outcomes Assessments, IQVIA, OpenEvidence, Technology Transformation, Content Licensing, Scholarly Publishing